Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration

Pharmacology Biochemistry and Behavior

Volumn 144, Issue , 2016, Pages 7-12

  Dong, Chao ^a   Zhang, Ji Chun ^a   Yao, Wei ^a   Ren, Qian ^a   Yang, Chun ^a   Ma, Min ^a   Han, Mei ^a   Saito, Ryo ^b   Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

^b MOCHIDA PHARMACEUTICAL CO   (Japan)

Author keywords

Antidepressant; Depression; Inflammation; Noradrenaline; Serotonin

Indexed keywords

CITALOPRAM; ESCITALOPRAM; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; REBOXETINE; TUMOR NECROSIS FACTOR ALPHA; MORPHOLINE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENANTIOMER; FORCED SWIM TEST; IMMOBILITY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; TAIL SUSPENSION TEST; ANIMAL; ANIMAL BEHAVIOR; BLOOD; C57BL MOUSE; DRUG EFFECTS; PSYCHOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; CITALOPRAM; DEPRESSION; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MORPHOLINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84959124220     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2016.02.005     Document Type: Article

References (33)

1. J.T. Andreasen, E.∅. Nielsen, J.K. Christensen, G.M. Olsen, D. Peters, N.R. Mirza, and J.P. Redrobe Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test J. Psychopharmacol. 25 10 2011 1347 1356
2. J.T. Andreasen, and J.P. Redrobe Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests Behav. Brain Res. 197 1 2009 150 156
3. J.F. Cryan, and A. Holmes The ascent of mouse: advances in modeling human depression and anxiety Nat. Rev. Drug Discov. 4 9 2005 775 790
4. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelly From inflammation to sickness and depression: when the immune system subjugates the brain Nature Rev. Neurosci. 9 1 2008 46 57
5. Y. Dowlati, N. Herrmann, W. Swardfager, H. Liu, L. Sham, E.K. Reim, and K.L. Lanctôt A meta-analysis of cytokines in major depression Biol. Psychiatry 67 5 2010 446 457
6. A.J. Dunn, A.H. Swiergiel, and R. de Beaurepaire Cytokines as mediators of depression: what can we learn from animal studies? Neurosci. Biobehav. Rev. 29 4-5 2005 891 909
7. E.W. Fish, S. Faccidomo, S. Gupta, and K.A. Miczek Anxiolytic-like effects of escitalopram, citalopram, and R-citalopram in maternally separated mouse pups J. Pharmacol. Exp. Ther. 308 2 2004 474 480
8. J. Haase, and E. Brown Integrating the monoamine, neurotrophin and cytokine hypotheses of depression-a central role for the serotonin transporter? Pharmacol. Ther. 147 2015 1 11
9. K. Hashimoto Emerging role of glutamate in the pathophysiology of major depressive disorder Brain Res. Rev. 61 2 2009 105 123
10. K. Hashimoto Inflammatory biomarkers as differential predictors of antidepressant response Int. J. Mol. Sci. 16 4 2015 7796 7801
11. J. Hyttel, K.P. Bøgesø, J. Perregaard, and C. Sánchez The pharmacological effect of citalopram residues in the (S)-(+)-enantiomer J. Neural Transm. Gen. Sect. 88 2 1992 157 160
12. W.W. Ji, S.Y. Wang, Z.Q. Ma, R.P. Li, S.S. Li, J.S. Xue, W. Li, X.X. Niu, L. Yanb, X. Zhangc, Q. Fua, R. Qud, and S.P. Ma Effects of perillaldehyde on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration Pharmacol. Biochem. Behav. 116 2014 1 8
13. M. Ma, Q. Ren, J.C. Zhang, and K. Hashimoto Effects of brilliant blue G on serum tumor necrosis factor-α levels and depression-like behavior in mice after lipopolysaccharide administration Clin. Psychopharmacol. Neurosci. 12 1 2014 31 36
14. E.N. McNamee, K.M. Ryan, E.W. Griffin, R.E. González-Reyes, K.J. Ryan, A. Harkin, and T.J. Connor Noradrenaline acting at central β-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration Brain Behav. Immun. 24 4 2010 660 671
15. A.H. Miller, V. Maletic, and C.L. Raison Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol. Psychiatry 65 9 2009 732 741
16. J.C. O'Connor, M.A. Lawson, C. André, M. Moreau, J. Lestage, N. Castanon, K.W. Kelley, and R. Dantzer Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice Mol. Psychiatry 14 5 2009 511 522
17. Y. Ohgi, T. Futamura, T. Kikuchi, and K. Hashimoto Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration Pharmacol. Biochem. Behav. 103 4 2013 856 859
18. M.J. Owens, D.L. Knight, and C.B. Nemeroff Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine Biol. Psychiatry 50 5 2001 345 350
19. C.L. Raison, C.A. Lowry, and G.A. Rook Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression Arch. Gen. Psychiatry 67 12 2010 1211 1224
20. Q. Ren, M. Ma, C. Yang, J.C. Zhang, W. Yao, and K. Hashimoto BDNF-TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms Transl. Psychiatry 5 2015 e666
21. C. Sánchez, and M. Kreilgaard R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram Pharmacol. Biochem. Behav. 77 2 2004 391 398
22. O.J.G. Schiepers, M.C. Wichers, and M. Maes Cytokines and major depression Prog. Neuro-Psychopharmacol. Biol. Psychiatry 29 2 2005 201 217
23. R.C. Shelton, J. Claiborne, M. Sidoryk-Wegrzynowicz, R. Reddy, M. Aschner, D.A. Lewis, and K. Mirnics Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression Mol. Psychiatry 16 7 2011 751 762
24. Sí Stórustovu, C. Sánchez, P. Pörzgen, L.T. Brennum, A.K. Larsen, M. Pulis, and B. Ebert R-citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter Br. J. Pharmacol. 142 1 2004 172 180
25. M.H. Trivedi, A.J. Rush, S.R. Wisniewski, A.A. Nierenberg, D. Warden, L. Ritz, G. Norquist, R.H. Howland, B. Lebowitz, P.J. McGrath, K. Shores-Wilson, and M.M. Biggs Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice Am. J. Psychiatry 163 1 2006 28 40
26. E.H. Wong, M.S. Sonders, S.G. Amara, P.M. Tinholt, M.F. Piercey, W.P. Hoffmann, D.K. Hyslop, S. Franklin, R.D. Porsolt, A. Bonsignori, N. Carfagna, and R.A. McArthur Reboxetine: a pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor Biol. Psychiatry 47 9 2000 818 829
27. World Health Organization (WHO) Depression. Fact sheet No. 369/October 2012. Available at http://www.who.int/mediacentre/factsheets/fs369/en/index.html.
28. C. Yang, Y. Shirayama, J.C. Zhang, Q. Ren, W. Yao, M. Ma, C. Dong, and K. Hashimoto R-ketamine: a rapid-acting and sustained antidepressant without psychotomimetic side effects Transl. Psychiatry 5 2015 e632
29. W. Yao, J.C. Zhang, C. Dong, C. Zhuang, S. Hirota, K. Inanaga, and K. Hashimoto Effects of amycenone on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administration Pharmacol. Biochem. Behav. 136 2015 7 12
30. J.C. Zhang, J. Wu, Y. Fujita, W. Yao, Q. Ren, C. Yang, S.X. Li, Y. Shirayama, and K. Hashimoto Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation Int. J. Neuropsychopharmacol. 18 4 2015 pyu077
31. J.C. Zhang, W. Yao, and K. Hashimoto Brain-derived neurotrophic factor (BDNF) - TrkB signaling in inflammation-related depression and potential therapeutic targets Curr. Neuropharmacol. 18 2016 Jan Epub ahead of print
32. H. Zhong, N. Haddjeri, and C. Sánchez Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter-a review of current understanding of its mechanism of action Psychopharmacology 219 1 2012 1 13
33. H. Zhong, K.B. Hansen, N.J. Boyle, K. Han, G. Muske, X. Huang, J. Egebjerg, and C. Sánchez An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant Neurosci. Lett. 462 3 2009 207 212